Bromophenol curcumin analog BCA-5 exerts an antiangiogenic effect through the HIF-1 alpha/VEGF/Akt signaling pathway in human umbilical vein endothelial cells

doi:10.1097/CAD.0000000000000671

IOCAS-IR > 实验海洋生物学重点实验室

	Bromophenol curcumin analog BCA-5 exerts an antiangiogenic effect through the HIF-1 alpha/VEGF/Akt signaling pathway in human umbilical vein endothelial cells
	Guo, Chuanlong 1,2,3,4; Wang, Lijun 1,2,3; Jiang, Bo 1,2,3; Shi, Dayong 1,2,3,4
	2018-11-01
发表期刊	ANTI-CANCER DRUGS
ISSN	0959-4973
卷号	29 期号:10 页码:965-974
摘要	The bromophenol curcumin analog 1,5-bis(3-bromo-4, 5-dimethoxyphenyl) penta-1, 4-dien-3-one (BCA-5) was assayed for antiangiogenic activity. Tandem mass tag labeling and liquid chromatography-tandem mass spectrometry were used to quantify the dynamic changes in the human umbilical vein endothelial cell (HUVEC) proteome. Functional annotation showed that BCA-5 might inhibit compounds related to the extracellular matrix, compounds that possess cytoskeletal protein-binding activity, and compounds that interact with cell motility-related enzymes, indicating antiangiogenic potential. In-vitro experiments have shown that BCA-5 inhibited HUVEC proliferation and induced HUVEC apoptosis. BCA-5 inhibited HUVEC migration, invasion, and tubular formation. BCA-5 decreased the phosphorylation of Akt and endothelial nitric oxide synthase; it also reduced the expression of hypoxia-inducible factor-1 alpha and vascular endothelial cell growth factor in a dose-dependent manner. These results suggest that BCA-5 has antiangiogenic properties and should be considered a potent antiangiogenesis drug for the treatment of cancer. Copyright (C) 2018 Wolters Kluwer Health, Inc. All rights reserved.
关键词	antiangiogenesis curcumin analogs hypoxia-inducible factor-1 alpha human umbilical vein endothelial cells vascular endothelial growth factor
DOI	10.1097/CAD.0000000000000671
收录类别	SCI
语种	英语
资助项目	Project of Discovery, Evaluation and Transformation of Active Natural Compounds, Strategic Biological Resources Service Network Programme of Chinese Academy of Sciences[ZSTH-026] ; Key Research Program of Frontier Sciences, CAS[QYZDB-SSW-DQC014] ; Taishan scholar Youth Project of Shandong province ; National Program for Support of Top-notch Young Professionals ; Shandong Provincial Natural Science Foundation for Distinguished Young Scholars[JQ201722] ; National Natural Science Foundation of China[81773586] ; National Natural Science Foundation of China[81703354] ; National Natural Science Foundation of China[81703354] ; National Natural Science Foundation of China[81773586] ; Shandong Provincial Natural Science Foundation for Distinguished Young Scholars[JQ201722] ; National Program for Support of Top-notch Young Professionals ; Taishan scholar Youth Project of Shandong province ; Key Research Program of Frontier Sciences, CAS[QYZDB-SSW-DQC014] ; Project of Discovery, Evaluation and Transformation of Active Natural Compounds, Strategic Biological Resources Service Network Programme of Chinese Academy of Sciences[ZSTH-026]
WOS研究方向	Oncology ; Pharmacology & Pharmacy
WOS类目	Oncology ; Pharmacology & Pharmacy
WOS记录号	WOS:000448390600005
出版者	LIPPINCOTT WILLIAMS & WILKINS
引用统计	被引频次：9[WOS] [WOS记录] [WOS相关记录]
文献类型	期刊论文
版本	出版稿
条目标识符	http://ir.qdio.ac.cn/handle/337002/156556
专题	实验海洋生物学重点实验室
通讯作者	Shi, Dayong
作者单位	1.Chinese Acad Sci, Inst Oceanol, CAS Key Lab Expt Marine Biol, Qingdao, Peoples R China 2.Chinese Acad Sci, Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China 3.Chinese Acad Sci, Ctr Ocean Mega Sci, Qingdao, Peoples R China 4.Univ Chinese Acad Sci, Beijing, Peoples R China
第一作者单位	中国科学院海洋研究所
通讯作者单位	中国科学院海洋研究所
推荐引用方式 GB/T 7714	Guo, Chuanlong,Wang, Lijun,Jiang, Bo,et al. Bromophenol curcumin analog BCA-5 exerts an antiangiogenic effect through the HIF-1 alpha/VEGF/Akt signaling pathway in human umbilical vein endothelial cells[J]. ANTI-CANCER DRUGS,2018,29(10):965-974.
APA	Guo, Chuanlong,Wang, Lijun,Jiang, Bo,&Shi, Dayong.(2018).Bromophenol curcumin analog BCA-5 exerts an antiangiogenic effect through the HIF-1 alpha/VEGF/Akt signaling pathway in human umbilical vein endothelial cells.ANTI-CANCER DRUGS,29(10),965-974.
MLA	Guo, Chuanlong,et al."Bromophenol curcumin analog BCA-5 exerts an antiangiogenic effect through the HIF-1 alpha/VEGF/Akt signaling pathway in human umbilical vein endothelial cells".ANTI-CANCER DRUGS 29.10(2018):965-974.